The Common Agriculture Policy (CAP), currently on the table of the European Parliament, is an opportunity for hemp producers to increase the tetrahydrocannabinol content of varieties grown in Europe. EIHA and MEPs worked together to increase the level from 0,2% to 0,3%.
On December 21, Donald Trump gave American hemp lovers a surprise. The President of the United States signed a Farm Bill – an act already approved by the Congress that effectively allows the cultivation of hemp at the federal level. The legal act known as ‘Hemp Farming Act of 2018’ removes hemp from the list of forbidden crops (at the federal level), thus giving green light to farmers living in all those states whose legislature has not yet regulated the case of industrial hemp.
TORONTO, August 21, 2018 — The Green Organic Dutchman Holdings Ltd. (the “Company” or “TGOD”) (TSX:TGOD) (US:TGODF) is pleased to announce it has signed a definitive agreement to acquire 100% of the issued and outstanding shares of privately-held HemPoland in an immediately accretive cash and share transaction.
- Acquisition cost of US$7.75 million in cash and 1,968,323 restricted TGOD shares currently worth US$7.75 million (~CAD$20.4 million combined) with an additional US$10.3 million (CAD$13.5 million) cash investment for rapid European expansion
- Additional performance based incentives of up to US$12 million (CAD$15.8 million) for delivery of US$32 million (CAD$42.1 million) of EBITDA in fiscal 2021
- European gateway with distribution channels to over 750 million people and sales in over 700 locations across 13 countries
- 32,000 kgs of dried flower production from 1,250 acres of cultivation
- Organic, innovative leading brand with diverse and novel product offerings including IP
- Premier selling CBD oil brand “Cannabigold”, a recognized leader in the EU
Mr Antonio Guterres
Secretary-General of the United Nations
23 July 2018
Dear Mr Secretary-General,
The fortieth meeting of the WHO Expert Committee on Drug Dependence (ECDD) convened from 4 to 7 June 2018 at WHO headquarters in Geneva. The fortieth ECDD meeting was dedicated to the review of cannabis and its component substances.
CND Resolution 52 5 noted that the health effects of cannabis had not been recently reviewed and requested the WHO ECDD to provide an updated report. The thirty-eighth ECDD (November, 2016) reviewed updates presented by the Secretariat and recognised an increase in the use of cannabis and its components for medical purposes and the emergence of new cannabis-related pharmaceutical preparations for therapeutic use. The Committee further recognised that cannabis had never been subject to a formal review and therefore recommended that pre-reviews of cannabis and its component substances be evaluated at a specific ECDD meeting dedicated to those substances.
The popularity of CBD products is growing exponentially Europewide. CBD food supplements are no longer used only to support therapies of those in need, but are increasingly becoming part of the daily diet of health-conscious and active individuals, who happily start their day with few drops of CannabiGold. As we know most of those who tried CBD are reluctant to miss on its benefits when going on vacation so during the summer our email accounts are flooded with questions regarding the transportation of CBD products across boarders More »
At the end of May, hemp industry was struck with the news of more than 50 victims of fake CBD oils in Utah. The mixture of the unclear regulations, chaos on the market and dishonesty of “producers” jumping on the cannabis bandwagon took its grim toll. In other states that have not regulated the issue of access to non-medical hemp products, the situation is not much better, and counterfeiting CBD is becoming a scourge. More »
Recently we examined in details how CBD interacts with the endocannabinoid system.This interaction is very complex and involves different ways of cannabidiol binding to receptor as well as its indirect effects (the most important being its impact on anandamide). On this occasion we mentioned that the effect of the most important cannabinoid of hemp on the human body is far more complex and not limited to interaction with the dedicated endocannabinoid system – it includes surprising impact on such different and diverse systems as the vanilloid, adenosine, dopamine, and even opioid systems. Continuing our mini-series, today we will look into the mechanism of how CBD interacts with one of the most important and comprehensive systems regulating a whole plethora bodily functions – the serotonin system. It’s been only recently that we started to recognize, let alone understand the impact CBD has on this system (as is the case with many of the cannabinoids’ less-obvious interactions), so although many findings suggesting that serotonin plays an important role in the beneficiary and medicinal properties of cannabidiol, there is no way yet to identify the exact mechanism and extent of this beneficial impact. Along with the complex nature of the CBD’s interaction with other systems, this proves just how complex and potent the substances from the natural pharmacopoeia can be. More »
The basic mechanism of how the cannabinoids work on the human body appears to be fairly simple and well known. According to this common knowledge, the cannabinoids somehow act on the endocannabinoid system, which, in turn, regulates all this bodily stuff (pressure, appetite, sleep, pain…). Simple, huh? Yet in practice the nature of the union between cannabinoids and their dedicated receptors is much more complicated. Today, we will focus on the most interesting of those precious plant compounds – cannabidiol. Soon enough we will discover not only that does CBD affect a wide array of other inner systems, but also that direct impact of the CBD on the receptors of the endocannabinoid system is problematic to say the least. Let’s take a closer look at the complicated nature of the impact the most important hemp compound has on human body. Once again we will discover how complex and multifarious substance CBD is. More »
Along with the popular knowledge about the beneficial properties of hemp so grows the confusion around the subject. Most consumers are already aware of the differences between hemp and marijuana, what the cannabinoids are, as well as of the role that CBD plays in the beneficial effects of cannabis. However, although the fact that CBD hemp oils are completely legal in Poland and no, they do not exhibit any psychoactive properties, some controversy is still associated with, for example, different types of CBD products and their origin, as well as with their alleged link to the “medical marijuana”. A couple of the most common myths about cannabidiol have been tackled with earlier, today we will focus on the controversial synthetic CBD. As we shall see – the issue of cannabinoids synthesized in the laboratory brings together many of the most obscure and controversial issues surrounding cannabis as such. Discussion of synthetic CBD will therefore inevitably require to revision of basics about cannabinoids and their pro-health or even therapeutic effect. More »
Today we are about to address a quite sensitive issue – the interaction of pharmaceutical drugs and cannabidiol. Although the CBD preparations available in Poland preparations do not possess the status of medicine, many people would use them for general health purposes – as they do with any other dietary supplement of plant origin. Used in this way, the CBD hemp oil should not produce any side effects, but what about taking it with pharmaceutical drugs at the same time?